Not applicableUnknownNCT02852850What this trial is testingIn Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative ColitisWho this might be right forUlcerative Colitis Shandong University 30
Early research (Phase 1)Study completedNCT00076180What this trial is testingHu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic LeukemiaWho this might be right forT-Cell Large Granular Lymphocytic LeukemiaLeukemia, T-Cell Large Granular Lymphocytic National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07419880What this trial is testingRe-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast CancerWho this might be right forTriple -Negative Breast Cancer Fudan University 46
Not applicableStudy completedNCT00267826What this trial is testingImmunopharmacological Effects of Rituximab in Atopic DermatitisWho this might be right forDermatitis, Atopic University of Bern 6
Testing effectiveness (Phase 2)Study completedNCT00048555What this trial is testingSafety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's Lymphoma Biogen 90
Testing effectiveness (Phase 2)Study completedNCT01016015What this trial is testingTemsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone SarcomaWho this might be right forMetastatic OsteosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Osteosarcoma+2 more National Cancer Institute (NCI) 178
Large-scale testing (Phase 3)Study completedNCT00049517What this trial is testingCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML LeukemiaWho this might be right forLeukemia Eastern Cooperative Oncology Group 657
Early research (Phase 1)Study completedNCT01969643What this trial is testingA Safety Study of SGN-LIV1A in Breast Cancer PatientsWho this might be right forHER2 Positive Breast NeoplasmsHormone Receptor Positive Breast NeoplasmsTriple Negative Breast Neoplasms+1 more Seagen Inc. 290
Early research (Phase 1)Looking for participantsNCT05652335What this trial is testingJNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) AmyloidosisWho this might be right forRelapsed or Refractory Multiple MyelomaPreviously Treated Amyloid Light-chain (AL) Amyloidosis Janssen Research & Development, LLC 180
Early research (Phase 1)Study completedNCT02216890What this trial is testingSafety Study of SGN-CD70A in Cancer PatientsWho this might be right forRenal Cell CarcinomaMantle-Cell LymphomaDiffuse, Large B-Cell, Lymphoma+1 more Seagen Inc. 38
Not applicableLooking for participantsNCT05664035What this trial is testingFrequency of SPAD in Adult PatientsWho this might be right forSpecific Antibody DeficiencyPredominantly Antibody Deficiencies University Hospital, Lille 99
Post-approval studies (Phase 4)Study completedNCT00144768What this trial is testingA Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated PatientsWho this might be right forMucopolysaccharidosis IHurler's SyndromeHurler-Scheie Syndrome+1 more Genzyme, a Sanofi Company 25
Large-scale testing (Phase 3)Study completedNCT00000117What this trial is testingIntravenous Immunoglobulin Therapy in Optic NeuritisWho this might be right forOptic Neuritis National Eye Institute (NEI)
Testing effectiveness (Phase 2)Study completedNCT00003820What this trial is testingRituximab in Treating Patients With Hodgkin's LymphomaWho this might be right forLymphomaHodgkin Lymphoma (Category)Nodular Lymphocyte Predominant Hodgkin Lymphoma Ranjana Advani 39
Testing effectiveness (Phase 2)UnknownNCT05138146What this trial is testingClinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue SarcomaWho this might be right forSarcoma, Soft Tissue Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT07318883What this trial is testingA Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung CancerWho this might be right forSquamous NSCLC Shanghai Henlius Biotech 720
Testing effectiveness (Phase 2)Looking for participantsNCT04495296What this trial is testingA Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Cancer Suzhou Transcenta Therapeutics Co., Ltd. 320
Early research (Phase 1)Study completedNCT02350673What this trial is testingIntravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid TumorsWho this might be right forSolid Tumors Hoffmann-La Roche 70
Testing effectiveness (Phase 2)Study completedNCT00217594What this trial is testingA Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndromes National Heart, Lung, and Blood Institute (NHLBI) 40
Not applicableNot Yet RecruitingNCT07544953What this trial is testingAmyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD PathologyWho this might be right forParkinson Disease Yonsei University 60